Patents by Inventor Mislav OREB

Mislav OREB has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240052387
    Abstract: The present invention relates to polypeptides which are galacturonate (GalA) reductase variants comprising at least one amino acid substitution at a position corresponding to K261 and/or R267. The present invention further relates to nucleic acid molecules encoding the polypeptides and to host cells containing said nucleic acid molecules. The present invention further relates to a method for the production of L-galactonate (GalOA) and/or other bio-based compounds, comprising the expression of said nucleic acid molecules, preferably in said host cells. The present invention also relates to the use of the polypeptides, nucleic acids molecule or host cells for the production of L-galactonate (GalOA) and/or other bio-based compounds, and/or for the recombinant fermentation of biomaterial containing D-galacturonate (GalA).
    Type: Application
    Filed: October 8, 2020
    Publication date: February 15, 2024
    Inventors: SIMON HARTH, MISLAV OREB, JUN-YONG CHOE
  • Patent number: 10308692
    Abstract: The present invention relates to polypeptides which are Gal2 variants comprising at least one amino acid substitution at a position corresponding to M435, and optionally further amino acid substitution(s). The present invention further relates to nucleic acid molecules encoding the polypeptides and to host cells containing said nucleic acid molecules. The present invention further relates to a method for the production of bioethanol and/or other bio-based compounds, comprising the expression of said nucleic acid molecules, preferably in said host cells. The present invention also relates to the use of the polypeptides, nucleic acids molecule or host cells for the production of bioethanol and/or other bio-based compounds, and/or for the recombinant fermentation of biomaterial containing pentose(s), preferably D-xylose and/or L-arabinose.
    Type: Grant
    Filed: October 22, 2015
    Date of Patent: June 4, 2019
    Assignee: Lallemand Hungary Liquidity Management LLC
    Inventors: Eckhard Boles, Alexander Farwick, Ferdinand Kirchner, Virginia Schadeweg, Mislav Oreb
  • Patent number: 10246495
    Abstract: The present invention relates to polypeptides which are Gal2 variants comprising at least one amino acid substitution at a position corresponding to T354, and optionally further amino acid substitution(s). The present invention further relates to nucleic acid molecules encoding the polypeptides and to host cells containing said nucleic acid molecules. The present invention further relates to a method for the production of bioethanol and/or other bio-based compounds, comprising the expression of said nucleic acid molecules, preferably in said host cells. The present invention also relates to the use of the polypeptides, nucleic acids molecule or host cells for the production of bioethanol and/or other bio-based compounds, and/or for the recombinant fermentation of biomaterial containing pentose(s), preferably D-xylose and/or L-arabinose.
    Type: Grant
    Filed: October 22, 2015
    Date of Patent: April 2, 2019
    Assignee: BUTALCO GMBH
    Inventors: Eckhard Boles, Heiko Dietz, Alexander Farwick, Virginia Schadeweg, Mislav Oreb
  • Publication number: 20170334955
    Abstract: The present invention relates to polypeptides which are Gal2 variants comprising at least one amino acid substitution at a position corresponding to M435, and optionally further amino acid substitution(s). The present invention further relates to nucleic acid molecules encoding the polypeptides and to host cells containing said nucleic acid molecules. The present invention further relates to a method for the production of bioethanol and/or other bio-based compounds, comprising the expression of said nucleic acid molecules, preferably in said host cells. The present invention also relates to the use of the polypeptides, nucleic acids molecule or host cells for the production of bioethanol and/or other bio-based compounds, and/or for the recombinant fermentation of biomaterial containing pentose(s), preferably D-xylose and/or L-arabinose.
    Type: Application
    Filed: October 22, 2015
    Publication date: November 23, 2017
    Inventors: Eckhard Boles, Alexander Farwick, Ferdinand Kirchner, Virginia Schadeweg, Mislav Oreb
  • Publication number: 20170283835
    Abstract: The present invention relates to polypeptides which are Gal2 variants comprising at least one amino acid substitution at a position corresponding to T354, and optionally further amino acid substitution(s). The present invention further relates to nucleic acid molecules encoding the polypeptides and to host cells containing said nucleic acid molecules. The present invention further relates to a method for the production of bioethanol and/or other bio-based compounds, comprising the expression of said nucleic acid molecules, preferably in said host cells. The present invention also relates to the use of the polypeptides, nucleic acids molecule or host cells for the production of bioethanol and/or other bio-based compounds, and/or for the recombinant fermentation of biomaterial containing pentose(s), preferably D-xylose and/or L-arabinose.
    Type: Application
    Filed: October 22, 2015
    Publication date: October 5, 2017
    Applicant: BUTALCO GMBH
    Inventors: Eckhard BOLES, Heiko DIETZ, Alexander FARWICK, Virginia SCHADEWEG, Mislav OREB